Juan Turnes
@jturnesv
Chief of Gastroenterology & Hepatology in @Pontegastro / @IISGaliciaSur / Associate Professor @UniversidadeUSC / SoMe Editor @LiverInt / SoMe Advisor @EASLnews
ID:273581909
https://www.linkedin.com/in/juan-turnes-8892b542/ 28-03-2011 19:30:01
13,2K Tweets
5,8K Followers
933 Following
Follow People
📅 Calentando motores para el curso de inteligencia artificial generativa que daremos el próximo miércoles 15 en Área Sanitaria de Pontevedra e O Salnés
🔑 Necesitamos incorporar la IA generativa a nuestros flujos de trabajo, pero para eso primero necesitamos formación!
➡️ bit.ly/3ynSAjQ
#AI
1+ 1 = 3
Lactulose + Rifaximin = Reduced episodes of hepatic encephalopathy
journals.lww.com/hepcomm/fullte…
Hepatology Communications
What is the impact of ONLY dietary and physical exercise on #MASLD ? A fantastic study from Veterans Affairs AJG - The American Journal of Gastroenterology:
🔑 No weight loss after 5 years
🔑 ⬆️ weight compared to no engagement
Any more hints that 💊 is here to stay?
#LiverTwitter
journals.lww.com/ajg/abstract/9…
Juan Turnes Hay que valorar el esfuerzo en ajustar el Lead-Time y Length-Time Bias. Sin embargo, el uso del Tiempo de Duplicación Tumoral y la ecuación de Schwartz es polémico y difícil que se parezca a la realidad.👇
Marina Varela Durán
AENOR Certifica con la norma ISO 9001 la Unidad de Reanimación del Complejo Hospitalario Universitario Pontevedra Área Sanitaria de Pontevedra e O Salnés Consellería de Sanidade Axencia Galega de Coñecemento en Saúde
🏥@SCISEDAR GTIPO-SEDAR SEDAR Javier Garcia Fernandez Susana Romero Flores
Carlos Crespo Diz Juan Turnes "QUÉ TIENE QUE SABER MI JEFE"
Clinical and genetic factors involved in Porto sinusoidal vascular disorder after oxaliplatin exposure. Last work of REHEVASC group!!! Asociación Española para el Estudio del Hígado DigestivoValdecilla IDIVAL Direccion IDIVAL
Digestive and Liver Disease, doi.org/10.1016/j.dld.…
Lithuania 🇱🇹 is setting an example for the 🌍 with Hepatitis C elimination program to reach World Health Organization (WHO) goals! In just over a year more than 50 percent of target population has been screened! EASLnews my_UEG
#livertwitter
Read more in the recent paper: bmcpublichealth.biomedcentral.com/articles/10.11…
Sarcopenia in patients with cirrhosis is associated with higher risk of decompensation including HE and death 💪🤯 how to evaluate and treat it is being reviewed by Aldo J. Montano-Loza in ISHEN translational
Very grateful to have our cirrhotic cardiomyopathy review published in Liver International. onlinelibrary.wiley.com/doi/10.1111/li…
Take-home messages:
1⃣ MRI is promising - infiltration/oedema/fibrosis
2⃣ Conflicting data on cardiac parameters in AD
3⃣ Need therapeutics not just symptom control